ABOS
Price
$1.61
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Capitalization
95.1M
22 days until earnings call
MSCLF
Price
$0.41
Change
-$0.01 (-2.38%)
Updated
Jul 25 closing price
Capitalization
68.29M
Interact to see
Advertisement

ABOS vs MSCLF

Header iconABOS vs MSCLF Comparison
Open Charts ABOS vs MSCLFBanner chart's image
Acumen Pharmaceuticals
Price$1.61
Change-$0.00 (-0.00%)
Volume$11.04K
Capitalization95.1M
SATELLOS BIOSCIENCE
Price$0.41
Change-$0.01 (-2.38%)
Volume$60.45K
Capitalization68.29M
ABOS vs MSCLF Comparison Chart in %
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MSCLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. MSCLF commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and MSCLF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (ABOS: $1.61 vs. MSCLF: $0.41)
Brand notoriety: ABOS and MSCLF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 2% vs. MSCLF: 72%
Market capitalization -- ABOS: $95.1M vs. MSCLF: $68.29M
ABOS [@Biotechnology] is valued at $95.1M. MSCLF’s [@Biotechnology] market capitalization is $68.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileMSCLF’s FA Score has 1 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • MSCLF’s FA Score: 1 green, 4 red.
According to our system of comparison, MSCLF is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 4 TA indicator(s) are bullish while MSCLF’s TA Score has 2 bullish TA indicator(s).

  • ABOS’s TA Score: 4 bullish, 4 bearish.
  • MSCLF’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, ABOS is a better buy in the short-term than MSCLF.

Price Growth

ABOS (@Biotechnology) experienced а +7.33% price change this week, while MSCLF (@Biotechnology) price change was -5.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

ABOS is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABOS($95.1M) has a higher market cap than MSCLF($68.3M). ABOS YTD gains are higher at: -6.395 vs. MSCLF (-30.017). MSCLF has higher annual earnings (EBITDA): -19.92M vs. ABOS (-111.98M). ABOS has more cash in the bank: 149M vs. MSCLF (41.2M). ABOS (0) and MSCLF (0) have equivalent revenues.
ABOSMSCLFABOS / MSCLF
Capitalization95.1M68.3M139%
EBITDA-111.98M-19.92M562%
Gain YTD-6.395-30.01721%
P/E RatioN/A2.24-
Revenue00-
Total Cash149M41.2M362%
Total Debt29MN/A-
FUNDAMENTALS RATINGS
MSCLF: Fundamental Ratings
MSCLF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
PROFIT vs RISK RATING
1..100
80
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
75
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABOSMSCLF
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
76%
MACD
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
69%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 10 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 13 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
83%
Aroon
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MSCLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RMTO0.08N/A
+6.13%
RM2 International, Inc.
NEOJF11.53N/A
N/A
NEOJAPAN INC.
CGMLF1.20N/A
N/A
Chalice Mining Ltd.
CSUAY17.88N/A
N/A
China Shenhua Energy Co., Ltd.
DIFTY26.09-0.10
-0.38%
Daito Trust Construction Co.

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with CRBU. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
N/A
CRBU - ABOS
52%
Loosely correlated
-3.80%
GLSI - ABOS
50%
Loosely correlated
+0.70%
BEAM - ABOS
50%
Loosely correlated
+3.68%
FHTX - ABOS
50%
Loosely correlated
N/A
SYRE - ABOS
48%
Loosely correlated
+1.08%
More

MSCLF and

Correlation & Price change

A.I.dvisor tells us that MSCLF and ATHE have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MSCLF and ATHE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MSCLF
1D Price
Change %
MSCLF100%
-1.69%
ATHE - MSCLF
28%
Poorly correlated
+15.32%
AKBLF - MSCLF
28%
Poorly correlated
N/A
VYGR - MSCLF
27%
Poorly correlated
-2.11%
ABOS - MSCLF
26%
Poorly correlated
N/A
PEPG - MSCLF
26%
Poorly correlated
+0.69%
More